IP Library › Assignment 027507/0396
Patent Assignment
Reel/Frame 027507/0396

Merger

Recorded: 2012-01-10 Pages: 10
Assignor
PROTEOLIX, INC.
Executed: 2009-11-16
Assignee
ONYX THERAPEUTICS, INC.
249 E. GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (6)
Compounds for Enzyme Inhibition
Patent: 8,207,124 →
Application: 13/334,263 →
Publication: US 2012/0094928
Compounds for Enzyme Inhibition
Patent: 8,207,125 →
Application: 13/334,288 →
Publication: US 2012/0101048
Compounds for Enzyme Inhibition
Patent: 8,324,174 →
Application: 13/334,372 →
Publication: US 2012/0101050
Compounds for Enzyme Inhibition
Patent: 8,207,126 →
Application: 13/334,466 →
Publication: US 2012/0094929
Compounds for Enzyme Inhibition
Patent: 8,207,297 →
Application: 13/334,469 →
Publication: US 2012/0094930
Compounds for Enzyme Inhibition
Patent: 8,207,127 →
Application: 13/334,544 →
Publication: US 2012/0094926
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 10, 2012
From: SMYTH, MARK S.; LAIDIG, GUY J.; BORCHARDT, RONALD T.; BUNIN, BARRY A.
To: PROTEOLIX, INC.
Reel/Frame 027506/0521 →
Assignment of Assignor's Interest Jan 10, 2012
From: SMYTH, MARK S.; LAIDIG, GUY J.
To: PROTEOLIX, INC.
Reel/Frame 027506/0588 →
Change of Address of the Assignee Nov 2, 2016
From: ONYX THERAPEUTICS, INC.
To: ONYX THERAPEUTICS, INC.
Reel/Frame 040878/0943 →